We are live on
!
Find out more
PA
Parkside Advisors Portfolio holdings
AUM
$455M
Turnover
13.19%
1-Year Est. Return
11.43%
This Fund
S&P 500
This Quarter
Est. Return
+1.41%
1 Year Est. Return
+11.43%
3 Year Est. Return
+36.7%
5 Year Est. Return
+49.36%
10 Year Est. Return
+85.96%
AUM
$141M
AUM Growth
-$1.58M
(-1.1%)
Cap. Flow
-$3.46M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
79.55%
Holding
34
New
1
Increased
8
Reduced
18
Closed
6
Avg Time Held
2.3
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$217K |
| 2 |
iShares MBS ETF
MBB
|
+$80K |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$49.1K |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$47.1K |
| 5 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$27.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$584K |
| 2 |
Johnson & Johnson
JNJ
|
+$365K |
| 3 |
IBM
IBM
|
+$289K |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$289K |
| 5 |
Agilent Technologies
A
|
+$257K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 98.97% |
| 2 | Technology | 0.52% |
| 3 | Consumer Staples | 0.18% |
| 4 | Energy | 0.17% |
| 5 | Healthcare | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
ExxonMobil
XOM
$725B
| $236K | 0.17% |
2,522
-2,000
| -44% | -$177K |
2013 Q4
10 quarters
|
|
|
27
Bristol-Myers Squibb
BMY
$126B
| $225K | 0.16% |
+3,064
| New | +$217K |
2016 Q2
0 quarters
|
|
28
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$460M
| $219K | 0.15% |
3,994
-210
| -5% | -$11.4K |
2014 Q1
9 quarters
|
|
|
29
Agilent Technologies
A
$49.4B
| – | – |
-6,438
| Closed | -$257K | – |
|
30
Hewlett Packard
HPE
$77B
| – | – |
-18,148
| Closed | -$187K | – |
|
31
HP
HPQ
$27.7B
| – | – |
-10,365
| Closed | -$128K | – |
|
|
32
IBM
IBM
$217B
| – | – |
-1,998
| Closed | -$289K | – |
|
|
33
Johnson & Johnson
JNJ
$625B
| – | – |
-3,374
| Closed | -$365K | – |
|
34
Target
TGT
$71.1B
| – | – |
-2,675
| Closed | -$220K | – |
|
Similar funds
MC
NC
JWCA
TFF
WWP
CF
SFA
SXL
Parkside Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, Parkside Advisors held 34 positions worth $141M, down 1.1% from $143M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Parkside Advisors's Q2 2016 filing shows 1 new, 8 increased, 18 reduced and 6 closed positions. Its largest new stake was Bristol-Myers Squibb: 3,064 shares worth $225K. The largest sale was iShares Russell 1000 Value ETF, an estimated $584K.
By sector, the portfolio is most concentrated in Miscellaneous at 99% of assets, up from 98% a quarter earlier, followed by Technology and Consumer Staples.
- Parkside Advisors's largest Q2 2016 buy was Bristol-Myers Squibb: 3,064 shares worth $225K.
- Parkside Advisors added most to iShares MBS ETF in Q2 2016, an estimated $80K increase.
- Parkside Advisors's biggest Q2 2016 reduction was iShares Russell 1000 Value ETF, cutting an estimated $584K.
- Parkside Advisors fully exited Johnson & Johnson in Q2 2016, selling an estimated $365K.
- Parkside Advisors's ten largest holdings make up 80% of its $141M portfolio in Q2 2016.
- Parkside Advisors opened 1 new position and closed 6 in Q2 2016.
- Parkside Advisors's portfolio value fell 1.1% quarter-over-quarter to $141M.
Based on Parkside Advisors's 13F filing for Q2 2016, filed 7 Jul 2016.